Ja. Taylor et al., RELATIONSHIP OF GROWTH STIMULATED BY LITHIUM, ESTRADIOL, AND EGF TO PHOSPHOLIPASE-C ACTIVITY IN MCF-7 HUMAN BREAST-CANCER CELLS, Breast cancer research and treatment, 34(3), 1995, pp. 265-277
Lithium-stimulated MCF-7 cell proliferation was compared to proliferat
ion stimulated by other mitogens for this cell line-estradiol (E(2)) a
nd epidermal growth factor (EGF) - and lithium was found to be effecti
ve within a narrow concentration range. Mitogenic effects of lithium o
n proliferation stimulated by E(2) and EGF were additive below maximum
, but were not synergistic. The phosphoinositide pathway is a cell sig
naling system involved in cell proliferation, within which phospholipa
se C (PLC)-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphat
e [PtdIns(4,5)P-2] leads to the production of the second messengers in
ositol-1,4,5-trisphosphate [Ins(1,4,5)P-2] and diacylglycerol (DAG), a
s well as to calcium mobilization. At mitogen concentrations which max
imally stimulated cell growth, estradiol stimulated both growth and PL
C activity, while EGF and lithium stimulated cell growth but had littl
e effect on the activity of the enzyme. Dose-responses with EGF reveal
ed that a low concentration (0.1 ng/ml, 0.017 nM) of EGF appeared to s
timulate both PLC activity and cell growth, but that higher concentrat
ions of EGF which stimulated greater proliferation inhibited PLC activ
ity. Steady-state levels of inositol phosphates including inositol tri
sphosphate were increased by all three mitogens. In growth assays, the
phorbol ester phorbol 12-myristate-13-acetate (PMA), which mimics the
actions of DAG, stimulated some cell growth, but dioctanoylglycerol,
an additional DAG analog, and the calcium ionophore A23187, alone or w
ith the DAG analogs, had no effect. These results suggest that PLC-med
iated PtdIns(4,5)P-2 hydrolysis is not primarily associated with signa
ling proliferation by lithium or EGF in MCF-7 breast cancer cells.